Henry Schein stock repurchase

Aug. 18, 2011
Program is in addition to $100 million repurchase program announced in November 2010 that  has been fully executed. 

MELVILLE, New York--Henry Schein, a provider of health-care products and services to office-based practitioners, has announced that its Board of Directors has authorized the repurchase of up to $200 million of shares of the company's common stock.

The program is in addition to the $100 million repurchase program announced in November 2010 that has been fully executed.

Dental catalogs offer integrated solutions

The company has approximately 91 million shares outstanding, and this new authorization represents approximately 3.5% of shares outstanding at the current stock price. Purchases may be made from time to time in the open market, or through negotiated transactions.

"During the first six months of the current fiscal year Henry Schein generated operating cash flow of approximately $185 million," said Stanley M. Bergman, chairman and chief executive officer of Henry Schein. "Our Board has determined that buying back additional shares represents an attractive investment, and is an appropriate means to continue building shareholder value."

For more information, visit www.henryschein.com.

To comment on this topic, go to community.pennwelldentalgroup.com/.